Figure 3. Figure 3. Comparison of the NNRTI-binding sites of wild-type and mutant HIV-1 RTs with bound inhibitors. a, Val106Ala with nevirapine; b, Val106Ala with UC-781; c, Val108Ile with nevirapine. Colour coding is the same as for Figure 2.